Northwestern Mutual Wealth Management CO Alnylam Pharmaceuticals, Inc. Transaction History

Northwestern Mutual Wealth Management CO

$118 Billion
Q4 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 476 shares of ALNY stock, worth $115,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

476

Previous 523 8.99%

Holding current value

$115,920

Previous $143,000 21.68%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$232.27 - $300.43 $10,916 - $14,120	-47 Reduced 8.99%	476 $112,000
Q3 2024 Nov 12, 2024	SELL	$233.81 - $287.01 $17,068 - $20,951	-73 Reduced 12.25%	523 $143,000
Q2 2024 Aug 15, 2024	BUY	$143.31 - $247.0 $35,827 - $61,750	250 Added 72.25%	596 $144,000
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $26,371 - $35,676	-180 Reduced 34.22%	346 $51,000
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $6,964 - $9,042	46 Added 9.58%	526 $100,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $7,684 - $9,524	45 Added 10.34%	480 $85,000
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $17,760 - $20,356	-96 Reduced 18.08%	435 $82,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $28,860 - $37,213	158 Added 42.36%	531 $106,000
Q4 2022 Feb 21, 2023	BUY	$185.53 - $241.31 $25,788 - $33,542	139 Added 59.4%	373 $88,000
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $22,997 - $38,512	-166 Reduced 41.5%	234 $47,000
Q2 2022 Aug 04, 2022	SELL	$120.42 - $169.29 $24,806 - $34,873	-206 Reduced 33.99%	400 $59,000
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $635 - $869	5 Added 0.83%	606 $98,000
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $29,713 - $40,861	231 Added 62.43%	601 $102,000
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $5,200 - $7,203	41 Added 12.46%	370 $52,000
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $2,582 - $3,087	21 Added 6.82%	329 $43,000
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $3,999 - $5,461	33 Added 12.0%	308 $45,000
Q1 2020 May 08, 2020	SELL	$93.12 - $133.99 $14,061 - $20,232	-151 Reduced 35.45%	275 $30,000
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $38,298 - $63,854	-514 Reduced 54.68%	426 $49,000
Q3 2019 Nov 12, 2019	BUY	$70.9 - $87.82 $11,202 - $13,875	158 Added 20.2%	940 $76,000
Q2 2019 Aug 12, 2019	BUY	$65.86 - $92.79 $5,334 - $7,515	81 Added 11.55%	782 $57,000
Q1 2019 May 10, 2019	BUY	$72.76 - $93.45 $37,180 - $47,752	511 Added 268.95%	701 $66,000
Q4 2018 Feb 12, 2019	BUY	$62.67 - $88.33 $6,267 - $8,833	100 Added 111.11%	190 $14,000
Q3 2018 Nov 01, 2018	BUY	$87.52 - $122.67 $7,876 - $11,040	90 New	90 $8,000

Others Institutions Holding ALNY

# of Institutions

670

Shares Held

112M

Call Options Held

839K

Put Options Held

771K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Alnylam Pharmaceuticals, Inc. Transaction History